Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (3)
  • 2022 (5)
  • 2021 (3)
  • 2020 (2)
  • 2019 (1)
  • 2017 (2)

Subject

  • Drug Trafficking (4016)
  • Synthetic drugs (1067)
  • Guns/Weapons (990)
  • OCDETF/Task Force (810)
  • Fake Pills (655)
  • Arrests/Convictions - Major (605)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (458)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Diversion Division (243)
  • Task Forces/Task Force Officers (231)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (111)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (7)
  • Critical Incident (6)
  • Scam Calls (5)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Intelligence Division - Intelligence Products (5)
  • Museum and Visitors Center (3)

Drug Name

  • Opioids (5)
  • Cocaine (3)
  • Fentanyl (2)
  • Heroin (2)
  • Hydromorphone (2)
  • Methamphetamine (2)
  • Oxycodone (2)
  • Synthetic Opioids (2)
  • Benzodiazepines (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)
  • Morphine (1)

Field Division

  • Washington, DC (7)
  • Headquarters (2)
  • Detroit (1)
  • Miami (1)
  • New England (1)
  • New Orleans (1)
  • Philadelphia (1)
  • Phoenix (1)
  • Rocky Mountain (1)
Clear All Results
PRESS RELEASE

DEA Releases 2025 National Drug Threat Assessment

May 15, 2025
WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...
May 15, 2025
PRESS RELEASE

India-Based Chemical Company and Top Employees Indicted for Unlawful Import of Fentanyl Precursor Chemicals

March 21, 2025
An India-based chemical manufacturing company and three high-level employees were charged in federal court in Washington, D.C., today related to illegally importing precursor chemicals used to make illicit fentanyl. According to the indictment, Vasudha Pharma Chem Limited (VPC), VPC Chief Global Business Officer Tanweer Ahmed Mohamed Hussain Parkar, 63, of...
March 21, 2025
PRESS RELEASE

DEA Rocky Mountain Field Division Executes Search Warrant on Known Tren de Aragua Gang Location in Metro Denver

January 26, 2025
DENVER – The Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) – in conjunction with federal and local partners – executed a federal search warrant on 6600 Federal Boulevard in Adams County, Colorado just before 5 a.m. MT today. Based on months-long investigative work, it was determined this makeshift nightclub...
January 26, 2025
PRESS RELEASE

DEA Dedicates September 11th Memorial

September 09, 2022
WASHINGTON - On Friday, September 9, 2022, the Drug Enforcement Administration dedicated a memorial at DEA Headquarters in Arlington, Virginia to DEA New York Drug Enforcement Task Force Officers who have lost their lives from illness or disease caused by their work at Ground Zero after the terrorist attacks of...
September 09, 2022
PRESS RELEASE

DEA Graduates the Sixth Annual Citizens Academy Class in Richmond, Virginia

July 29, 2022
Richmond, Va., – The United States Drug Enforcement Administration is active in many local communities through Operation Engage, a comprehensive community-level approach to address the drug epidemic through prevention strategies, facilitating conversations, and collaboration with local partners. As part of this mission, Citizens Academies are held to connect field offices...
July 29, 2022
PRESS RELEASE

DEA Launches Second Year of Operation Engage

March 23, 2022
PHOENIX – The United States Drug Enforcement Administration (DEA) Special Agent in Charge (SAC) Cheri Oz is pleased to announce the launching of the second year of Operation Engage, a comprehensive community-level approach to address the drug epidemic through prevention strategies, facilitating conversations and collaboration with local partners. “DEA’s priority...
March 23, 2022
PRESS RELEASE

DEA Serves Immediate Suspension Order on Northgate Pharmacy in Waldorf, Maryland

January 27, 2022
Washington, D.C., - Jarod Forget, Special Agent in Charge of the DEA Washington Division, announced the issuance of an Immediate Suspension Order (ISO) at Northgate Pharmacy, located at 3973 Saint Charles Parkway, Waldorf, Maryland, today. This morning, members of the Drug Enforcement Administration (DEA) Washington Division’s Tactical Diversion Squad, along...
January 27, 2022
PRESS RELEASE

Former Virginia Veterinarian Pleads Guilty to Drug Charges

January 24, 2022
LYNCHBURG, Va. – A Madison Heights, Virginia man and former veterinarian pleaded guilty to a pair of misdemeanor drug charges related to his diversion of hydromorphone, an opioid drug also known under the trade name of “Dilaudid.” Patrick Gries, 54, pleaded guilty last week to one count of adulteration of...
January 24, 2022
PRESS RELEASE

Charlottesville Dermatologist Sentenced for Diverting Pain Medication

July 30, 2021
CHARLOTTESVILLE, Va., – A dermatologist formerly employed at a dermatological practice in the City of Charlottesville was sentenced last week to 12 months probation, including a period of home confinement and electronic monitoring, for using the Drug Enforcement Administration (DEA) registration number of her co-workers to obtain prescription opioid pain...
July 30, 2021
PRESS RELEASE

North Carolina Man Pleads Guilty to Conspiring to Distribute Suboxone, Oxycodone, other Pain Medications

July 29, 2021
ABINGDON, Va., – A Dobson, North Carolina man pleaded guilty yesterday to conspiring to distribute medically illegitimate prescriptions for Schedule II opioids and Suboxone, as well as conspiring to use, in the course of the distribution of controlled substances, the DEA registration number of another person. According to court documents...
July 29, 2021
Showing 1 - 10 of 16 results

Pagination

  • Current page 1
  • Page 2
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster